Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « decrease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
decoys < decrease < decreased  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000008 (2010) P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]Tocilizumab
000013 (2013) Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
000017 (2011) Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000092 (2009) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
000143 (2012) Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000234 (2012) G. Lippi [Italie] ; G. Targher [Italie]Optimal therapy for reduction of lipoprotein(a)
000282 (2010) Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne]Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
000284 (2012) Usama Elewa [Espagne] ; Maria Dolores Sanchez-Ni O [Espagne] ; Catalina Martin-Cleary [Espagne] ; Beatriz Fernandez-Fernandez [Espagne] ; Jesus Egido [Espagne] ; Alberto Ortiz [Espagne]Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled
000294 (2013) Shunsei Hirohata [Japon] ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon] ; Masahisa Kyogoku [Japon]TNF inhibitors induce discoid fibrosis in the sublining layers of the synovium with degeneration of synoviocytes in rheumatoid arthritis
000462 (2013) Reinhard P. T. Rychlik [Allemagne]Target patient population: how does the regulatory and reimbursement view differ? Insights from the German IQWiG
000511 (2011) Stefan Kleinert [Allemagne] ; Hans-Peter Tony [Allemagne] ; Andreas Krause [Allemagne] ; Martin Feuchtenberger [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Constanze Richter [Allemagne] ; Ekkehard Röther [Allemagne] ; Wolfgang Spieler [Allemagne] ; Holger Gnann [Allemagne] ; Bianca M. Wittig [Allemagne]Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
000512 (2010) Aharon Kessel [Israël] ; Regina Peri [Israël] ; Tharwat Haj [Israël] ; Ayelet Snir [Israël] ; Gleb Slobodin [Israël] ; Edmond Sabo [Israël] ; Itzhak Rosner [Israël] ; Yehuda Shoenfeld [Israël] ; Elias Toubi [Israël]IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
000576 (2013) Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie]Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury
000588 (2013) Y. Urata ; Y. Nakamura ; S. Motomura [Japon]AB0592 Decrease of tocilizumab by monitoring serum IL-6 with sustained triple remission in rheumatoid arthritis: 6-star
000713 (2011) M. Korppi [Finlande] ; Me Van Gijn [Pays-Bas] ; K. Antila [Finlande]Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report
000907 (2013) M. Murakami [Japon] ; T. Matsutani [Japon] ; C. Aoki [Japon] ; H.-M. Lee [Japon] ; Y. Li [Japon] ; N. Nishimoto [Japon]THU0378 Interleukin-6 blocking therapy by tocilizumab in patients with multicentric castleman’s disease results in a significant decrease in serum levels of IgG4 and IGE
000A57 (2011) Mara Anaís Llamas-Covarrubias [Mexique] ; Yeminia Valle [Mexique] ; Rosa Elena Navarro-Hernández [Mexique] ; Iris Paola Guzmán-Guzmán [Mexique] ; María Guadalupe Ramírez-Due As [Mexique] ; Héctor Rangel-Villalobos [Mexique] ; Ciro Estrada-Chávez [Mexique] ; José Francisco Mu Oz-Valle [Mexique]Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course
000B18 (2013) S. Perrier D Auterive [Belgique] ; S. Kesseler [Belgique] ; P. Ruggeri [Belgique] ; M. Timmermans [Belgique] ; O. Gaspard [Belgique] ; T. Kumke [Allemagne] ; G. Parker [Royaume-Uni]FRI0160 Certolizumab PEGOL did not result in a decrease in semen quality in healthy volunteers: Results from a phase 1 study
000C63 (2011) Eric Röhner [Allemagne] ; Georg Matziolis [Allemagne] ; Carsten Perka [Allemagne] ; Bernd Füchtmeier [Allemagne] ; Timo Gaber [Allemagne] ; Gerd-Rüdiger Burmester [Allemagne] ; Frank Buttgereit [Allemagne] ; Paula Hoff [Allemagne]Inflammatory synovial fluid microenvironment drives primary human chondrocytes to actively take part in inflammatory joint diseases
000C66 (2012) K. Minden [Allemagne] ; M. Niewerth [Allemagne]Rheumakranke Kinder und Jugendliche
000C73 (2013) Mislav Radic [Croatie] ; Dusanka Martinovic Kaliterna [Croatie] ; Josipa Radic [Croatie]Overview of vasculitis and vasculopathy in rheumatoid arthritis—something to think about

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "decrease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "decrease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    decrease
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021